ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,771Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 12

$503K Total Retail Price of All Prescriptions

Rank: 8 out of 12

206 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 206 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

19% of this provider’s 206 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

1% of this provider’s 7,662 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
FUROSEMIDE 467 460 1 2
WARFARIN SODIUM 365 355 2 8
LISINOPRIL 351 248 3 1
SIMVASTATIN 320 182 4 3
LEVOTHYROXINE SODIUM 299 244 5 4
AMLODIPINE BESYLATE 272 207 6 7
METOPROLOL TARTRATE 262 231 7 10
DONEPEZIL HCL 219 216 8 9
OMEPRAZOLE 191 158 9 6
METFORMIN HCL 178 87 10 12
FAMOTIDINE 160 117 11 46
NAMENDA 159 159 12 11
POTASSIUM CHLORIDE 159 106 12 13
HYDROCODONE-ACETAMINOPHEN 158 147 S3 14 5
IBUPROFEN 150 78 15 80
HEPARIN SODIUM 139 139 16 97
KLOR-CON M10 133 123 17 100
ATORVASTATIN CALCIUM 111 91 18 18
RISPERIDONE 106 77 19 28
PANTOPRAZOLE SODIUM 106 77 19 31
BENZTROPINE MESYLATE 104 45 R 21 82
GABAPENTIN 101 83 22 14
TAMSULOSIN HCL 101 79 22 27
CITALOPRAM HBR 92 89 24 15
ESCITALOPRAM OXALATE 92 82 24 25
QUETIAPINE FUMARATE 85 76 26 40
FENTANYL 81 75 S2 27 32
HYDROCHLOROTHIAZIDE 80 31 28 16
OXYBUTYNIN CHLORIDE ER 78 78 29 128
ABILIFY 77 74 30 79
TRAMADOL HCL 74 59 31 20
SERTRALINE HCL 73 58 32 17
MIRTAZAPINE 73 61 32 24
DIGOXIN 73 72 32 42
RANITIDINE HCL 71 18 35 44
DIVALPROEX SODIUM 69 42 36 30
LANTUS 67 65 37 23
NOVOLIN R 67 47 37 144
TRAZODONE HCL 66 55 39 37
CARVEDILOL 62 48 40 26
METOPROLOL SUCCINATE 62 37 40 21
KLOR-CON M20 60 54 42 54
MEGESTROL ACETATE 55 33 R 43 160
CLOPIDOGREL 53 49 44 33
GLIPIZIDE 53 53 44 71
EXELON 51 50 46 61
LYRICA 50 50 47 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 18, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.